Table 4.
Subset analysis of lymphocytes from PD patients stratified by disease onset (45 years as the cut-off).
| Group | CD3+ T | CD3+CD4+ T | CD3+CD8+ T | CD19+ B | NK |
|---|---|---|---|---|---|
| (62%–76%) | (32%–46%) | (18%–32%) | (7%–18%) | (7%–18%) | |
| Early-onset | 64.74 ± 5.93 | 33.68 ± 4.06 | 23.64 ± 5.13 | 12.21 ± 6.04 | 20.11 ± 7.32 |
| Late-onset | 62.82 ± 9.44 | 33.53 ± 7.78 | 23.68 ± 8.70 | 11.08 ± 4.83 | 23.11 ± 10.22 |
| P-value | 0.063 | 0.023 | 0.161 | 0.417 | 0.067 |
UPDRS, unified Parkinson’s disease rating scale; H&Y stage, Hoehn–Yahr stage; NMSS, Non-motor Symptoms Scale for Parkinson’s disease; SD, standard deviation; UPDRS III, motor function evaluation. Mean ± SD.